Brightlight Capital Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-106,600
Closed -$3.41M 10
2024
Q3
$3.41M Hold
106,600
1.64% 11
2024
Q2
$8.75M Buy
106,600
+60,450
+131% +$6.54M 4.68% 8
2024
Q1
$6.69M Sell
46,150
-30,000
-39% -$2.53M 3.78% 9
2023
Q4
$7.01M Buy
76,150
+30,673
+67% +$3.12M 5.06% 10
2023
Q3
$7.5M Hold
45,477
5.27% 8
2023
Q2
$2.87M Hold
45,477
2.35% 9
2023
Q1
$1.54M Hold
45,477
0.7% 10
2022
Q4
$2.63M Hold
45,477
1.11% 12
2022
Q3
$4.28M Sell
45,477
-9,136
-17% -$1.3M 3.08% 10
2022
Q2
$12.2M Hold
54,613
7.64% 7
2022
Q1
$30M Hold
54,613
12.62% 1
2021
Q4
$36.1M Buy
54,613
+14,558
+36% +$11.1M 14.44% 1
2021
Q3
$33.6M Buy
40,055
+8,120
+25% +$8.24M 14.4% 2
2021
Q2
$40.5M Buy
31,935
+6,275
+24% +$7.08M 14.53% 1
2021
Q1
$28.1M Sell
25,660
-4,610
-15% -$6.09M 11.66% 4
2020
Q4
$43.2M Sell
30,270
-12,110
-29% -$12.9M 17.58% 1
2020
Q3
$29.9M Sell
42,380
-1,630
-4% -$1.19M 14.13% 3
2020
Q2
$30.8M Hold
44,010
15.71% 3
2020
Q1
$15.4M Buy
44,010
+16,720
+61% +$11.8M 11.84% 1
2019
Q4
$17.2M Buy
+27,290
New +$13.3M 12.97% 2

Other funds holding CDLX

Brightlight Capital Management's CDLX Position: Q4 2024 in Review

Brightlight Capital Management sold out of Cardlytics (CDLX) in Q4 2024, closing a stake of 106,600 shares — an estimated $3.41M sold.

Brightlight Capital Management first reported a position in CDLX in Q4 2019 and held it in 20 quarters. The position peaked at $43.2M in Q4 2020. 108 funds tracked by Wall St. Rank hold CDLX as of Q4 2024.

  • Brightlight Capital Management reported no remaining Cardlytics position as of Q4 2024 after selling out during the quarter.
  • Brightlight Capital Management sold 106,600 Cardlytics shares in Q4 2024, an estimated $3.41M.
  • Brightlight Capital Management first reported a position in Cardlytics in Q4 2019 and held it in 20 quarters.
  • Brightlight Capital Management's Cardlytics position peaked at $43.2M in Q4 2020.
  • 108 funds tracked by Wall St. Rank held Cardlytics as of Q4 2024.

Based on Brightlight Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.